The global pandemic caused by the coronavirus has had far-reaching and long-lasting impacts. The disease's entire breadth has yet to be discovered. Initially, there were multiple anecdotal and published reports of eye redness and irritation in COVID-19 patients, implying that conjunctivitis is an ocular symptom of SARS-CoV-2 infection. COVID-19 has been linked to uveitic, retinovascular, and neuro-ophthalmic illness, according to new research. Based on the findings in the patients' eyes, it's been indicated that unprotected eyes can also become infected with the SAR-CoV-2 virus. The drugs used to treat COVID-19 have ocular side effects as well. Although long-term treatment of chloroquine and hydroxychloroquine can cause retinal damage, this is neither expected or seen with COVID-19.
Title : Coenzyme Q10 for the protection of lacrimal gland against high-dose radioiodine therapy associated oxidative damage: histopathologic and tissue cytokine level assessments in an animal model
Nihat Yumusak, Department of Pathology, Turkey
Title : Glaucoma tubes and their blebs. A personal reflection on the south african connection to the development of glaucoma tube shunts and their blebs
Jeffrey Freedman, Emeritus at State University of New York, United States
Title : (Un)avoidable errors in biometry and some ideas how to overcome them
Sibylle Scholtz, Institute of Experimental Ophthalmology, Germany
Title : A comparative assessment of dry eye disease among the farmers and office going people
Jyoti Bala Pandre , Aurobindo Nethralaya, India
Title : Rare and interesting case of choroidal melanoma presenting as a case of a congestive glaucoma left eye in a 55 years old male patient
Gowhar Ahmad, Florence Hospital multi-speciality center chanapora Srinagar Kashmir, India
Title : To evaluate the safety and efficacy of half fluence photodynamic therapy for symptomatic peripapillary circumscribed choroidal hemangiomas (CCHS)
Prabhjot Singh, Armed Forces Medical College, India